Commentary
Combining retinoic acid and oral arsenic may be potentially the first-line therapy for non-high-risk acute promyelocytic leukemia
Stem Cell Investigation
2016;
3:
93
(19 December 2016)
Commentary
Novel methods for the treatment of liver fibrosis using in vivo direct reprogramming technology
Stem Cell Investigation
2016;
3:
92
(09 December 2016)
Editorial
Cell sources for regenerative medicine of the liver and endoderm organs: strategies and perspectives
Stem Cell Investigation
2016;
3:
91
(09 December 2016)
Review Article
Wilms tumor 1 peptide vaccination after hematopoietic stem cell transplant in leukemia patients
Stem Cell Investigation
2016;
3:
90
(09 December 2016)
Editorial
Comment on: Expandable cardiovascular progenitor cells reprogrammed from fibroblasts
Stem Cell Investigation
2016;
3:
89
(09 December 2016)
Commentary
Blocking TGF-β and BMP SMAD-dependent cell differentiation is a master key to expand all kinds of epithelial stem cells
Stem Cell Investigation
2016;
3:
88
(08 December 2016)
Case Report
Bone marrow derived stem cell therapy for type 2 diabetes mellitus
Stem Cell Investigation
2016;
3:
87
(06 December 2016)
Perspective
The silver lining of induced pluripotent stem cell variation
Stem Cell Investigation
2016;
3:
86
(06 December 2016)
Original Article
BCR/ABL can promote CD19+ cell growth but not render them long-term stemness
Stem Cell Investigation
2016;
3:
85
(30 November 2016)
Review Article
Hypomethylating agents after allogeneic blood stem cell transplantation
Stem Cell Investigation
2016;
3:
84
(28 November 2016)
Original Article
Enrichment of skin-derived neural precursor cells from dermal cell populations by altering culture conditions
Stem Cell Investigation
2016;
3:
83
(23 November 2016)
Editorial
Harnessing TGF-β and BMP signaling for expansion of p63-positive epithelial stem cells
Stem Cell Investigation
2016;
3:
82
(15 November 2016)
Commentary
Editing genetics, stem cells are prophetic, what’s the best way to model cells of diabetics?
Stem Cell Investigation
2016;
3:
81
(15 November 2016)
Editorial
Studying pancreas development and diabetes using human pluripotent stem cells
Stem Cell Investigation
2016;
3:
80
(14 November 2016)
Short Report
The Vox mRNA and protein expression in zebrafish Pou5f3 MZspg mutant embryos
Stem Cell Investigation
2016;
3:
79
(14 November 2016)
Editorial
Efficient CRISPR/Cas9-based gene correction in induced pluripotent stem cells established from fibroblasts of patients with sickle cell disease
Stem Cell Investigation
2016;
3:
78
(14 November 2016)
Commentary
E-cadherin adhesion-mediated Wnt activation for mesoderm specification in human embryonic stem cells needs a soft mattress
Stem Cell Investigation
2016;
3:
77
(14 November 2016)
Editorial
Genome editing in human pluripotent stem cells: a systematic approach unrevealing pancreas development and disease
Stem Cell Investigation
2016;
3:
76
(14 November 2016)
Editorial
TGF-β: a master regulator of the bone marrow failure puzzle in Fanconi anemia
Stem Cell Investigation
2016;
3:
75
(07 November 2016)
Commentary
Spotlight on the Schwann cells during the regeneration
Stem Cell Investigation
2016;
3:
74
(07 November 2016)
Perspective
The paradox of Foxd3: how does it function in pluripotency and differentiation of embryonic stem cells?
Stem Cell Investigation
2016;
3:
73
(04 November 2016)
Editorial
Unraveling the mysteries of pre-mRNA splicing in the retina via stem cell technology
Stem Cell Investigation
2016;
3:
72
(04 November 2016)
Review Article
Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma
Stem Cell Investigation
2016;
3:
70
(31 October 2016)
Editorial
p38α-mediated purine metabolism is linked to exit from quiescence of hematopoietic stem cells
Stem Cell Investigation
2016;
3:
69
(31 October 2016)